Arca
Skip to content

Nm Application Suite

System, Image Processing, Radiological. 510(k) K080961, from Philips Nuclear Medicine, Inc. (Milpitas, CA). Product code LLZ, class 2.

As of Nov 17, 2026, K080961 is an FDA 510(k) held by Philips Nuclear Medicine, Inc., substantially equivalent on Apr 18, 2008 after 14 days, with 1 recall tied to it in FDA's recall database.

  • Substantially equivalent: Apr 18, 2008
  • Review time: 14 days
  • Recalls: 1
  • Cited as a predicate by: 3 devices

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

A nuclear medicine image display and processing application suite that provides software applications used to process, analyze, and display medical images/data. The results obtained may be used as a tool, by a nuclear physician, in determining the diagnosis of patient disease conditions in various organs, tissues, and other anatomical structures.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a Predicate

3 later 510(k) summaries name this device as a predicate

Recalls

Recalls FDA ties to K080961, newest first; each opens FDA's recall record
StartedReasonStatus
Sep 15, 2011Z-0182-2012A problem related to a software error has been detected in the Philips Multiple Gated Radionuclide Angiocardiography (MUGA) application. A false negative interpretation due to a falsely elevated ejection fraction or a…Terminated

Other LLZ Clearances

The newest 510(k)s for the same product code; their median review was 110 days; see every LLZ device

Record

Type
Traditional, third-party review
Received
Apr 4, 2008
Review panel
Radiology
Regulation
21 CFR 892.2050

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.